Article ID Journal Published Year Pages File Type
2047629 FEBS Letters 2015 7 Pages PDF
Abstract

•Isoniazid, an anti-tuberculosis pro-drug, is activated by the KatG.•Tryptophan 78 occupies the entrance at the γ-edge side of the heme.•The structure of KatG-W78F reveals that an INH molecule binds in γ-edge of heme.•One-residue substitution in SeKatG dramatically changed the INH binding site.

Isoniazid (INH) is a pro-drug that has been extensively used to treat tuberculosis. INH is activated by the heme enzyme catalase–peroxidase (KatG), but the mechanism of the activation is poorly understood, in part because the INH binding site has not been clearly established. Here, we observed that a single-residue mutation of KatG from Synechococcus elongatus PCC7942 (SeKatG), W78F, enhances INH activation. The crystal structure of INH-bound KatG-W78F revealed that INH binds to the heme pocket. The results of a thermal-shift assay implied that the flexibility of the SeKatG molecule is increased by the W78F mutation, allowing the INH molecule to easily invade the heme pocket through the access channel on the γ-edge side of the heme.

Related Topics
Life Sciences Agricultural and Biological Sciences Plant Science
Authors
, , , , , ,